CNE100000NG5
CNE100000NG5
XINBANG PHAR.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 5.85B EUR | 5.07B EUR | 6.38B EUR |
Enterprise Value | 4.97B EUR | 4.09B EUR | 5.65B EUR |
Valuation Multiples | |||
Trailing P/E | 50.17x | 30.65x | 40.91x |
Forward P/E | 12.54x | -- | -- |
Price to Sales | 1.12x | 1.31x | 1.55x |
Price to Book | 0.85x | 0.75x | 0.93x |
EV/Revenue | 0.95x | 1.06x | 1.38x |
EV/EBITDA | 10.79x | 14.86x | 22.25x |
Price to FCF (P/FCF) | 6.27x | 9.5x | 29.66x |
EV/FCF | 5.32x | 7.66x | 26.28x |
FCF Yield | 15.95% | 10.52% | 3.37% |